Christopher L. Carpenter, Chief Medical Officer at Rubius Therapeutics, Inc. (RUBY), sold 96,000 shares at $10.13 ($970K) on 2019-09-16, disclosed to the SEC on 2019-09-18.
Open-market sale of $970k RUBY by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.13 | 36,123 | $366K | 37.7% |
| 2 | $10.13 | 36,123 | $366K | 37.7% |
| 3 | $10.05 | 11,877 | $119K | 12.3% |
| 4 | $10.05 | 11,877 | $119K | 12.3% |
| Total | $10.11 avg | 96,000 | $970K | 100% |
| Filing → |
| RUBY | SELL | 2019-06-19 | $1.1M | — | Filing → |
| RUBY | SELL | 2019-03-19 | $760K | — | Filing → |